Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.77M | 5.27M | 4.27M | 4.13M | 4.59M |
Gross Profit | 5.60M | 4.12M | 3.32M | 3.45M | 4.15M |
EBITDA | 350.00K | -3.22M | -989.00K | -1.29M | -3.72M |
Net Income | -1.29M | -4.62M | -3.10M | -3.33M | -5.49M |
Balance Sheet | |||||
Total Assets | 7.40M | 7.81M | 11.15M | 14.20M | 12.59M |
Cash, Cash Equivalents and Short-Term Investments | 1.03M | 886.00K | 1.90M | 5.36M | 1.97M |
Total Debt | 5.06M | 4.65M | 3.59M | 3.66M | 3.77M |
Total Liabilities | 9.63M | 8.91M | 7.97M | 7.49M | 7.64M |
Stockholders Equity | -2.23M | -1.10M | 3.18M | 6.71M | 4.95M |
Cash Flow | |||||
Free Cash Flow | 268.00K | -2.00M | -2.97M | -802.00K | -1.90M |
Operating Cash Flow | 1.42M | -879.00K | -2.12M | -47.00K | -942.00K |
Investing Cash Flow | -1.16M | -1.16M | -848.00K | -755.00K | -961.00K |
Financing Cash Flow | -122.00K | 1.04M | -535.00K | 4.19M | 2.84M |
KRM22 plc has reported a positive trading update for the first half of 2025, with an increase in Annual Recurring Revenue (ARR) from £6.6m to £7.2m, driven by cross-sales and price increases. Despite some customer churn, the company maintains a strong sales pipeline and expects to meet market expectations by year-end. The cash balance improved to £1.4m, and KRM22 continues to focus on careful cash management while aiming to become a cash-generative and profitable business.
KRM22 plc has issued 56,075 new ordinary shares to partially satisfy deferred consideration related to its acquisition of Object+. This move, representing 0.2% of the company’s issued share capital, is part of a strategy to conserve cash. The newly issued shares are expected to commence trading on AIM on 24 July 2025. This decision underscores KRM22’s strategic approach to managing its financial obligations while maintaining operational liquidity, potentially impacting shareholder interests and market positioning.
KRM22 plc announced that Sandy Broderick, a Non-Executive Director, purchased 22,974 ordinary shares of the company, increasing his beneficial interest to 34,739 shares, which represents 0.1% of the company’s issued share capital. This transaction underscores confidence in KRM22’s strategic direction and could positively influence stakeholder perception, potentially impacting the company’s market positioning and investor relations.
KRM22 plc announced the issuance of 2,025,147 Restricted Stock Units (RSUs) to its employees, including significant allocations to CEO Dan Carter and CFO Kim Suter. This issuance is part of a long-term incentive plan linked to the company’s FY24 financial performance and represents a strategic move to align employee interests with company growth. The RSUs will vest in five years and are not subject to future performance conditions, indicating a stable incentive structure. This development underscores KRM22’s commitment to fostering internal investment and aligning leadership with shareholder interests, potentially enhancing its market positioning and stakeholder confidence.
KRM22 plc has announced the posting of its Annual Report & Accounts for the year ended 31 December 2024, along with the notice of its 2025 Annual General Meeting (AGM). The AGM is scheduled to take place on 27 June 2025 in London. This announcement is significant as it reflects the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting its market positioning and stakeholder relations.
KRM22 plc announced that Garry Jones, the Non-Executive Chairman, has purchased 6,279 ordinary shares of the company, increasing his beneficial interest to 282,750 shares, representing 0.8% of the issued share capital. This transaction highlights confidence in the company’s strategic direction and could positively impact stakeholder perception, reinforcing KRM22’s commitment to enhancing value through its risk management solutions in the capital markets sector.
KRM22 plc reported strong financial results for the year ending December 31, 2024, with a 22.2% increase in Annualised Recurring Revenue (ARR) to £6.6 million and a maiden adjusted EBITDA profit of £1.0 million. The company signed 12 new ARR contracts, launched the Risk Manager application, and implemented a cost savings program. Board changes included appointing Dan Carter as CEO and Garry Jones as Non-Executive Chairman. Post year-end, ARR grew to £7.4 million, and the company deferred interest payments on a convertible loan with Trading Technologies International, Inc. KRM22 is well-positioned for growth, with a strong sales pipeline and high client satisfaction, as it expands its market coverage into new asset classes.